
Episode 4 of Supply Chain Signal examines PhRMA’s legal challenge to CMS ’ GLOBE model and whether manufacturers can lower costs, expand U.S. production and strengthen supply chain resilience all at once.
over 4 years ago
2022 Patient Support Vendor Directoryover 4 years ago
Pharmaceutical Commerce - April 2022 Issue (PDF)over 4 years ago
Diving in Headfirstover 4 years ago
Oncology Innovation: Optimism & Obstaclesover 4 years ago
The Pulse of Rare Disease Supportover 4 years ago
Patient Centricity: Banishing Buzzwordsover 4 years ago
Adding Might to ‘Specialty Lite’over 4 years ago
Success with SP Solutionsover 4 years ago
Hub Programs from Patient Perspectiveover 4 years ago
Patient Support in Europe





